Hi fellow PhD students,
I am looking for the following article: PHASE II, OPEN-LABEL, RANDOMIZED STUDY (SIGN) OF SINGLE-AGENT GEFITINIB (IRESSA) OR DOCETAXEL AS SECOND-LINE THERAPY IN PATIENTS WITH ADVANCED (STAGE IIIB OR IV) NON-SMALL-CELL LUNG CANCER.
Anyone happens to have access? I will be very grateful!
Thank you in advance